相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents
Dushyant Patel et al.
BIOORGANIC CHEMISTRY (2020)
Donepezil plus chromone plus melatonin hybrids as promising agents for Alzheimer's disease therapy
Irene Pachon-Angona et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy
Eva Ramos et al.
MOLECULES (2019)
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Dushyant Patel et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Oxidative stress and the amyloid beta peptide in Alzheimer's disease
C. Cheignon et al.
REDOX BIOLOGY (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
Synthesis, cytotoxic evaluation and DNA binding study of 9-fluoro-6H-indolo[2,3-b]quinoxaline derivatives
Zhenyu Gu et al.
RSC ADVANCES (2017)
Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity
Alanna McEneny-King et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation
Mahesh Shidore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening
Satish N. Dighe et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of isoalloxazine derivatives as a new class of potential anti-Alzheimer agents and their synthesis
Ashish M. Kanhed et al.
BIOORGANIC CHEMISTRY (2015)
Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/beta Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease
Anshuman Sinha et al.
MOLECULAR NEUROBIOLOGY (2015)
New Melatonin-N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer's Disease
Beatriz Lopez-Iglesias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Multifunctional tacrine flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease
Su-Yi Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Metal dyshomeostasis and oxidative stress in Alzheimer's disease
Mark A. Greenough et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Synthesis and cytotoxicity of novel 6H-indolo[2,3-b]quinoxaline derivatives
Sreenivas Avula et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Curcumin Protects Human Keratinocytes against Inorganic Arsenite-Induced Acute Cytotoxicity through an NRF2-Dependent Mechanism
Rui Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine
Gerda Brunhofer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations
Wenbo Yu et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)
Carbamate Derivatives of Indolines as Cholinesterase Inhibitors and Antioxidants for the Treatment of Alzheimer's Disease
Inessa Yanovsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands
Jonah Cheung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard J. O'Brien et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)
CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY
Miroslav Pohanka
BIOMEDICAL PAPERS-OLOMOUC (2011)
The Revitalized Tau Hypothesis on Alzheimer's Disease
Ricardo B. Maccioni et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Oxidative stress in Alzheimer disease: A possibility for prevention
David J. Bonda et al.
NEUROPHARMACOLOGY (2010)
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
Bayani Uttara et al.
CURRENT NEUROPHARMACOLOGY (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Comparison of Blood-Brain Barrier Permeability Assays: In Situ Brain Perfusion, MDR1-MDCKII and PAMPA-BBB
Li Di et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Multi-target-directed ligands to combat neurodegenerative diseases
Andrea Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity
Joachim Hartmann et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
RM Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties
MI Rodríguez-Franco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
High throughput artificial membrane permeability assay for blood-brain barrier
L Di et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Butyrylcholinesterase: An important new target in Alzheimer's disease therapy
NH Greig et al.
INTERNATIONAL PSYCHOGERIATRICS (2002)
Acetylcholinesterase in Alzheimer's disease
VN Talesa
MECHANISMS OF AGEING AND DEVELOPMENT (2001)
Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K
P Mark et al.
JOURNAL OF PHYSICAL CHEMISTRY A (2001)
分享论文
